March 30, 2026 | Pre- Congress Workshops

March 31 - April 2, 2026 | Main Congress Days

WALTER E. WASHINGTON CONVENTION CENTER, WASHINGTON D.C.

R&D + Strategic Partnering
for the Global Vaccine Industry

BOOK TICKET - 70% OFF

APPLY TO SPONSOR /EXHIBIT /SPEAK

WORLD’S LEADING VACCINE EVENT

4,000+

Attendees

550+

Speakers

300+

Exhibitors

100+

Start-ups

4

Days

12

Tracks

15

Workshops

2,500+

Partnering Meetings

The Most Important Vaccine Event of The Year

CONFERENCE

550+ SPEAKERS

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

APPLY TO SPEAK

EXHIBITION

MEET YOUR MARKET

300+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions

EXHIBIT / SPONSOR NOW

NETWORKING

IN-PERSON

Networking is at the heart of World Vaccine Congress Washington. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking

GET YOUR TICKETS

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure

Immune Profiling
Explores recent efforts into infectious disease modelling, immune characterization and T/B cell interplay.

Pandemic Platforms
The most promising platforms that can be used for an outbreak, from pathogen adaptability to speed, scale up and implementation

Cancer & Immunotherapy
Cancer vaccines and the future of combination treatments

Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery

Market Access
Understand the dynamics governing global vaccine markets & what interventions can be made for better access

Influenza & Respiratory
Latest updates in RSV, influenza, pneumococcal, pan- and combinational vaccines

Vaccine Safety
New tools to measure vaccine surveillance, safety and managing misinformation

Veterinary
A one health approach to battle emerging zoonotic diseases and climate change

Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up

Partnerships
Secure funding and navigate through successful Public-Private-Partnerships with all stakeholders

Emerging & Re-Emerging Diseases
From Disease X preparedness, neglected diseases to global health vaccine development & new platforms

GET YOUR TICKETS

APPLY TO SPEAK

2025 SPEAKERS

Karen Acker
Assistant Professor of Clinical Pediatrics
Weill Cornell Medicine

Richard Amlot
Deputy Director, Behavioural Science and Insights
UK Health Security Agency
Annaliesa Anderson
SVP and Head, Vaccine R&D
Pfizer

Asimenia Angelidou
Assistant Professor of Pediatrics,
Harvard Medical School
Kabeer Aziz
Partner
Adjuvant Capital

Irnela Bajrovic
VP of Alliances
Jurata Thin Film, Inc.
Inna Ben-Anat
Global Head, Manufacturing 4.0
Sanofi

Georges Benjamin
Executive Director
American Public Health Association
Maria Elena Bottazzi
Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Michelle Brown
Vice President, Portfolio Lead, Oncology
Moderna Therapeutics
Lynlee Burton
Vice President, Project Management, Infectious Diseases and Vaccines
Syneos Health

Alison M Buttenheim Mba
Professor
University of Pennsylvania
Paolo Casali
UT Ashbel Smith Professor and Distinguished Prof of Microbiology Immunology & Molecular Genetics
UT Health San Antonio

Francesca Ceddia
Chief Medical Affairs Officer
Moderna
Lee-Jah Chang
Head of Clinical Development, Vaccines and Immune Therapies
AstraZeneca

Dennis Christensen
Head of Global R&D
Croda
Matthew G. Clark
Joint Project Manager, CBRN Medical
JPEO-CBRND

Hazel Clothier
Lead Epidemiologist, Vaccine Safety, Center for Health Analytics
Mudoch Childrens Research Institute
Tim Cooke
CEO
Omniose

Don Diamond
Director, Division of Vaccine Research & Professor, Dept of Hem & HCT
City of Hope Comprehensive Cancer Center
Anna Durbin
Professor
Johns Hopkins Bloomberg School of Public Health

Mark Emalfarb
Chief Executive Officer
Dyadic International Inc
Jay Evans
Chief Scientific and Strategy Officer
Inimmune

Daniel Faissol
Principal Investigator, Center for Bioengineering, Executive Director, Predictive Design of Biologics
Lawrence Livermore National Laboratory
William Falstich
Vice President, Global Supply Chain, Primary Care
Pfizer

Donna Farber
Chief, Division of Surgical Sciences and Professor of Microbiology & Immunology
Columbia University
Stephen Framil
Corporate Global Head of Accessibility
Merck & Co. Inc.

Stine Friis
Director, Business Development
Evaxion Biotech A/S
Jimmy Gollihar
Head of Antibody Discovery and Accelerated Protein Therapeutics (ADAPT)
Houston Methodist Hospital

Swati Gupta
VP, Head of Emerging Infectious Diseases and Epidemiology
International AIDS Vaccine Initiative
Bassam Hallis
Deputy Director, Vaccine Development & Evaluation Centre
UK Health Security Agency

David Hamer
Professor of Global Health and Medicine
Boston University School of Public Health
Jenny Harries
Chief Executive Officer
UK Health Security Agency

Renee Hart
President & CBO
LumaCyte
Bill Hausdorff
Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and
PATH, Center for Vaccine Innovation and Access

Ana Maria Henao-Restrepo
Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE),
World Health Organisation
Matthew Hepburn
Chief Medical Officer
JPEO-CBRND

Jaime E Hernandez
Executive Medical Director, Clinical Development
Syneos Health
Adrian Hill
Director and Professor
The Jenner Institute - University of Oxford

James Hodge
Jr., J.D., LL.M, Peter Kiewit Foundation Professor of Law, Director, Center for Public Health Law and Policy
Arizona State University
Stephen Hoffman
Chief Executive And Scientific Officer
Sanaria

Richard Hughes IV
Partner, Epstein, Becker & Green
The George Washington University Law School
Lecia Imbery
Government Affairs Director
Vaccinate Your Family

Ashley Kalinauskas
Founder
Torigen Pharmaceuticals
Maria Karasarides
Former Vice President, Worldwide Medical Oncology, Early Assets & Biomarkers
The Delphina Group

Pravin Kaumaya
Professor & Director
Indiana university School of Medicine
Jerome Kim
Director General
IVI

Neville Kisalu
Senior Scientist Cellular Immunology Section, Vaccine Research Center
NIH - National Institute of Allergy and Infectious Diseases
Sabra L Klein
Professor of Molecular Microbiology and Immunology
Johns Hopkins Bloomberg School of Public Health

Charles Kline
Associate Vice President
Merck
Phil Krause
Consultant and Former FDA
Independent

Mahesh Kumar
Senior VP, Global Biologics R&D
Zoetis
Rekha Lakshmanan
Chief Strategy Officer
The Immunization Partnership

Paul Lawrence
Director of Research and Development
Bimeda
Luigi Lay
Lecturer -Department of Chemistry
University of Milan

Alexandre Le Vert
Chief Executive Officer
Osivax
Ofer Levy
Director, Precision Vaccines Program
Boston Children's Hospital

Tom Mahoney
Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Alessandro Manenti
Chief Development Officer
Vismederi

John Mattison
Operating Partner, Chief Medical Information Officer
Arsenal Capital Partners
Francesca Micoli
Director GVGH Innovation Academy and Senior Project Leader
GVGH

Kayvon Modjarrad
Executive Director, Viral Vaccines
Pfizer
Flor Munoz
Associate Professor Of Pediatrics-Infectious Disease
Baylor College of Medicine

Derek O'Hagan
Senior Advisor in R&D
GSK Vaccines
Masaru (Rusty) Oshita
MD
Apex Research Group / QCR Network

Mayur Patel
VP Global R&D Product Development and Portfolio Management
Elanco
Gabriela Paz-Bailey
Chief of the Dengue Branch
CDC

Amy Pisani
Chief Executive Officer
Vaccinate Your Family
Gregory Poland
Director of Mayo Vaccine Research Group
Mayo Clinic

Bali Pulendran
Director, Institute for Immunity, Transplantation and Infection
Stanford University School of Medicine (USA)
Marlen Ramirez
CHW/CHWI, Programs Coordinator
Vaccinate Your Family

Raman Rao
Chief Executive Officer
Hilleman Laboratories Singapore Pte Ltd
Ruben Rizzi
SVP Global Regulatory Affairs
BioNTech SE

Michelle Roberts
Head of medical RSV Franchise, Vaccines
Sanofi
Jerald Sadoff
Chief Medical Officer
Centivax

Sushant Sahastrabuddhe
Deputy Director General
Shift Health
Daniel Salmon
Director, Institute for Vaccine Safety
Johns Hopkins Bloomberg School of Public Health

Rafick-Pierre Sékaly
Professor and Vice-Chair of Translational Medicine
Emory University - School of Medicine
Alessandro Sette
Professor
La Jolla Institute for Allergy and Immunology

Angela Shen
Consultant
University of Pennsylvania
Lindsey Shields
Deputy Director, Epidemic Prepardness and Response
PATH

Lora Shimp
Director - Immunization Center
John Snow Inc
Jeffrey Skolnik
Senior Vice President, Clinical Development
Inovio Pharmaceuticals

Denise Smith
Inaugural Executive Director
National Association of Community Health Workers
Pilar Snowden
Medical Director, RSV
GSK

Mike Stebbins
Sr. Vice President
ATI - Advanced Technology International
Walter Straus
Vice President, Clinical Safety & Risk Management
Moderna Therapeutics

Julie Suman
Vice President, Scientific Affairs
Aptar Pharma
Petro Terblanche
Chief Executive Officer
Afrigen Biologics (Pty) Ltd

Thomas Tillett
Chief Executive Officer
MBF Therapeutics
Sean Tucker
CSO
Vaxart

Richard Webby
Director, World Health Organization Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds
St. Jude Children's Research Hospital
Markus Winterberg
Head of Analytical Development, Microbiology, and Quality Control
LTS Lohmann

Prashant Yadav
Senior Fellow
Council on Foreign Relations
Larry Zeitlin
President
Mapp Biopharmaceutical, Inc.

Robert Allen
Chief Scientific Officer
Invivyd
Shweta Bansal
Professor of Biology
Georgetown University

Erwin Blomsma
Chief Executive Officer
ViroVet
Michael Breen
Scientist
Tiba Biotech

Margherita Coccia
Director
GSK
Aaron Cowley
CSO
ReciBioPharm

Kashmira Date
Senior Director, Medical & Scientific Affairs (Pipeline Vaccines)
pfizer
William Decker
Professor
Baylor College of Medicine

Olivera (Olja) Finn
Distinguished Professor, Department of Immunology
University of Pittsburgh
Claudia-Nanette Gann
Vice President Clinical Development
BioNTech

Douglas Gladue
Vice President Veterinary Pharmaceutical Development
Seek Labs
Kathryn Hashey
Global Vaccine Policy & Government Affairs
GSK

Tim Hirst
CEO
GPN Vaccines Ltd
Aemro Kassa
Senior Associate Director, Viral Vaccine Exploration
Boehringer Ingelheim Animal Health

Anjalee Khemlani
Senior Reporter
Yahoo! Finance
Alasdair King
Executive Director, International Veterinary Health
Merck Animal Health

Alana Knudson
Director
NORC Walsh Center for Rural Health Analysis
Arvind Kumar
Vice President of Research
BiomEdit

Prabuddha Kumar Kundu
Co-founder and MD
Premas Biotech
Alex Mann
Director
Hvivo

Justine McPartlan
Scientist
Tiba Biotech
Lisa Purcell
Entrepreneur-In-Residence
Third Rock Ventures, LLC

Hagen Richter
Head of Nucleic Acids Research
Wacker Biotech
Zeil Rosenberg
Executive Vice President, Medical
Tonix Pharmaceuticals

Litjen (L.J) Tan
Chief Policy and Partnerships Officer
Immunize.org
Robert van der Put
Director Business Development
Intravacc

David Weiner
Executive Vice President: Director of Vaccine and Immunotherapy Center
The Wistar Institute
Thomas Campi
CEO
Modulant Biosciences

Patrick Duffy
Laboratory Chief
NIAID, NIH
Bernard Hoet
Vice President of Medical Strategy
Bavarian Nordic A/S

Sarah S. Long
Emeritus Chief, Infectious Diseases, St. Christopher’s Hospital for Children; Past member, ACIP, VRBPAC, Professor of Pediatrics
Drexel University College of Medicine
Ahmed Ogwell
Senior Advisor
United Nations Foundation

Angamuthu Selvapandiyan
Professor
Jamia Hamdard
Katie Van Tornhout
Founder
Callie Cares

Tonya Colpitts
AVP, Global Project Head, Vaccines
Sanofi
Lisa Cornbrooks
Senior Director of National Health Campaigns
American Medical Group Association AMGA

Sheetij Dutta
Chief Laboratory of Structural Vaccinology, Biologics Research and Development Branch
Walter Reed Army Insitute of Research
Joanie Robertson
Program Advisor
PATH

Niranjan Sardesai
President & Chief Executive Officer, Founder
Geneos Therapeutics
Thomas Acciani
Director, US Vaccine Policy
GSK

Lovisa Afzelius
Founding CEO and Chair, Apriori Bio; General Partner
Flagship Pioneering
Jorge Armero Gimenez
Platform Development Scientist
LenioBio GmbH

Rafik Bekkat-Berkani
Vice President, Global Medical Lead Vaccines
GSK
Jenna Benefield
Associate Partner
McKinsey and Company

Marie Bonhomme
Director
PPD, part of Thermo Fisher Scientific
Abby Bownas
Manager, AVAC ; Partner, NVG
NVG LLC

Gabrielle Breugelmans
Director of Epidemiology and Data Science
CEPI
Carolyn Bridges
Director for Adult Immunization
Immunize.org

Chris Buck
Senior Investigator
National Cancer institute
Mia Castagnero
Director, Business Development
Clinical Research IO (CRIO)

Maya Chandrasekaran
Director
Social Science Research Council
Ling Chen
Professor
Guangzhou Medical University,Guangzhou, China

Ghania Chikh
Senior Director, Vaccine Development
Acuitas Therapeutics, Inc.
Kati Chilikova
Manager Health Policy Research
Economist Impact

Steven Damon
CEO
Micron Biomedical
Kyle Doolan
Director of Research
Integral Molecular

Susanne Eder-Lingelbach
VP Clinical Development
Valneva
Angela Eichler
Director, Specialty Lab Services
JCCT

Pernille Elverdal
SrVP, Global RA, Clinical Evidence,Medical affairs
SSI Diagnostica A/S
Pascal Geldsetzer
Assistant Professor of Medicine
Stanford University

Volker Gerdts
Director and Chief Executive Officer
VIDO
Michinari Hamaguchi
Director General
AMED SCARDA

Jian (Jason) He
Executive Director, Head of BD and CMC
WuXi Vaccines
Jennifer Heller
Partner
McKinsey and Company

Klaus Hellmann
Head of Europe CRO
Argenta
Lisa Hensley
Distinguished Senior Research Scientist Research Lead - Zoonotic and Emerging Disease Research Unit
USDA

xuefei huang
professor
Michigan State University
Juan Carlos Jaramillo
Chief Medical Officer
Valneva

Elizabeth Joseph
Research Scientist II
Simtra BioPharma Solutions
Elizabeth Linderbaum
Deputy Director of Regulatory Affairs,
National Association of Community Health Centers Inc

Vega Masignani
Alliance Director
CARB-X
Sujatha Narayan
Principal Regulatory Program Director
Genentech

Tiffany Nation
Head of Regulatory Affairs Biologicals, US and Primary Market
Boehringer Ingelheim Animal Health USA Inc
Jonas Nguh
Immediate Past President
Maryland Public Health Association

May Pidding
Director, Microneedle Array Patch Product Management
LTS Lohmann
Robert Popovian
Chief Science Policy Officer
Global Healthy Living Foundation

Kevin Russell
Associate Vice President, Global Clinical Development, Vaccines
Merck Research Laboratories
Tyler Sandberg
Product manager
MABTECH

Giuseppe Sautto
Assistant Professor
Cleveland Clinic
Hanneke Schuitemaker
CSO
Valneva Austria GMBH

Joachim Seipelt
CBO
Nuvonis Technologies GmbH
Jonathan E Snyder
Senior Advisor, External Innovation
Elanco

José Martín Solórzano González
Scientific Coordinator
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol (IDIAP )
Katy Stein
Virology Scientist
Microbiologics

Katarina Stenklo
Senior Product Manager
Cytiva
Vianney Tricou
Senior Director, Medical & Scientific Affairs
Takeda Pharmaceuticals International AG

Isaac Uwins
Senior Analyst
Airfinity
Roland Ventura
VFI Senior Advisor for Strategy
Vaccine Formulation Institute

Felipe Villalobos
Scientific Coordinator
Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol (IDIAP )
Kelly Warfield
President, R&D
Sabin Vaccine Institute

Alan Young
Chief Technology Officer
Medgene Labs
Seth Berkley
Senior Advisor,
Pandemic Center at Brown Univertsity

Robert Chen
Scientific Director
BRIGHTON Collaboration
Michelle Cortez
Senior Editor / Chief Health Correspondent
Bloomberg News

Peter Dull
Deputy Director, Integrated Clinical Vaccine Development, Vaccine Development, Global Health Division
Gates Foundation
Rick Hill
President
IABS

Michael Kowarik
CSO
LimmaTech Biologics AG
Ruth Montgomery
Professor
Yale University

Robert Sitrin
Senior Scientist
PATH
Rochelle Chaiken
Chief Medical Officer
Vaxxas

Christian Mandl
CSO
Tiba Biotech

GET YOUR TICKETS

SEE 2025 SPEAKER LIST

SPONSOR OR EXHIBIT

Remaining marketing opportunities for world class solution providers are selling fast.
Contact: Michael.Hodge@terrapinn.com

GET THE SPONSORSHIP
& EXHIBITION BROCHURE

“This is a unique forum where at every corner one can learn about the challenges and innovations in the vaccine world. I have attended many conferences, but the WVC is one where I always leave with the feeling that I have learned significantly in three days.”

- Rochester Institute of Technology

“The presentations and panels were very informative. They captured and discussed both the current landscape in the vaccines world, issues and opportunities being faced by both patients, NGOs and governmental agencies.”

- Merck & Co.

“The work put into this event was apparent, from start to finish. It was engaging, accommodating, educational, and dare I say FUN.”

- EmVenio

“The most beneficial congress I ever attended in my career. The emphasis on bringing diverse professionals under one roof and the WVC organizers facilitating networking opportunities are truly supreme aspects of this congress.“

- TurboVax Inc.

“Fabulous content, great networking opportunities, and super location.”

- DHHS/ASPR

R&D + Strategic Partnering
for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

2025 SPEAKERS

2025 Sponsors and Exhibitors

Created by

R&D + Strategic Partnering for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

2025 SPEAKERS

2025 Sponsors and Exhibitors

Created by

R&D + Strategic Partnering
for the Global Vaccine Industry